Bahl & Gaynor Inc’s Amgen Inc Position
Does Bahl & Gaynor Inc own Amgen Inc (AMGN)? Yes — 195.9K shares worth $69M (+0.35% of its 13F portfolio) as of Q1 2026, down from 197.0K shares the prior filed quarter.
Position Value
$69M
Q1 2026
Shares
195.9K
% of Portfolio
+0.35%
Quarters Held
30
currently held
Position History AMGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 195.9K | $69M | +0.35% |
| Q4 2025 | 197.0K | $64M | +0.33% |
| Q3 2025 | 198.4K | $56M | +0.28% |
| Q2 2025 | 288.9K | $81M | +0.41% |
| Q1 2025 | 293.4K | $91M | +0.47% |
| Q4 2024 | 308.7K | $80M | +0.43% |
| Q3 2024 | 414.3K | $133M | +0.69% |
| Q2 2024 | 575.0K | $180M | +1.00% |
| Q1 2024 | 612.8K | $174M | +0.97% |
| Q4 2023 | 606.6K | $175M | +1.05% |
| Q3 2023 | 445.4K | $120M | +0.76% |
| Q2 2023 | 405.9K | $90M | +0.55% |
| Q1 2023 | 624.4K | $151M | +0.81% |
| Q4 2022 | 420.5K | $110M | +0.69% |
| Q3 2022 | 446.2K | $101M | +0.67% |
| Q2 2022 | 424.2K | $103M | +0.68% |
| Q1 2022 | 434.6K | $105M | +0.77% |
| Q4 2021 | 457.7K | $103M | +0.58% |
| Q3 2021 | 741.9K | $158M | +0.97% |
| Q2 2021 | 750.8K | $183M | +1.11% |
| Q1 2021 | 812.2K | $202M | +1.28% |
| Q4 2020 | 864.6K | $199M | +1.27% |
| Q3 2020 | 880.4K | $224M | +1.59% |
| Q2 2020 | 885.2K | $209M | +1.57% |
| Q1 2020 | 882.5K | $179M | +1.56% |
| Q4 2019 | 872.9K | $210M | +1.46% |
| Q3 2019 | 839.3K | $162M | +1.17% |
| Q2 2019 | 1.00M | $185M | +1.37% |
| Q1 2019 | 1.00M | $191M | +1.75% |
| Q4 2018 | 1.34M | $260M | +2.78% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bahl & Gaynor Inc’s full portfolio or all institutional holders of AMGN.